PURPOSE: Esthesioneuroblastomas, also called olfactory neuroblastomas (ENB) represent a rare sinonasal neurectodermal tumour which prognostic factors are unsteadily described. PATIENTS AND METHODS: Clinical and pathological characteristics were analysed in patients treated at Gustave Roussy Institute between 1979 and 2009. RESULTS: Out of 63 patients, 19 patients were reclassified and 44 patients were eligible for the analysis. Multivariate analysis revealed that T staging of the modified Dulguerov TNM staging and Hyams grade>III (that we termed high-grade ENB) were the only independent prognostic factors for overall survival (OS). As compared to patients with low-grade ENB (Hyams grade ≤ III), patients with high-grade ENB have higher T4 staging (p=0.02), have frequent lymph node involvement (p=0.009) and are more often unresectable (p=0.005). Resected patients with high-grade ENB frequently displayed mainly leptomeningeal metastasis (n=4/6) in contrast to patients with low-grade ENB who typically experience late loco-regional recurrence (n=10/25). With a median follow-up of 9.6 years, median DFS and OS for resected low-grade ENB were 5.4 and 20.5 years, respectively. Conversely, median DFS and OS for high-grade ENB were 1.5 and 2.5 years, respectively. CONCLUSION: Low and high-grade ENB display distinct patterns at presentation and relapse, leading to different prognosis. Therefore, they may be regarded as distinct entities.
PURPOSE:Esthesioneuroblastomas, also called olfactory neuroblastomas (ENB) represent a rare sinonasal neurectodermal tumour which prognostic factors are unsteadily described. PATIENTS AND METHODS: Clinical and pathological characteristics were analysed in patients treated at Gustave Roussy Institute between 1979 and 2009. RESULTS: Out of 63 patients, 19 patients were reclassified and 44 patients were eligible for the analysis. Multivariate analysis revealed that T staging of the modified Dulguerov TNM staging and Hyams grade>III (that we termed high-grade ENB) were the only independent prognostic factors for overall survival (OS). As compared to patients with low-grade ENB (Hyams grade ≤ III), patients with high-grade ENB have higher T4 staging (p=0.02), have frequent lymph node involvement (p=0.009) and are more often unresectable (p=0.005). Resected patients with high-grade ENB frequently displayed mainly leptomeningeal metastasis (n=4/6) in contrast to patients with low-grade ENB who typically experience late loco-regional recurrence (n=10/25). With a median follow-up of 9.6 years, median DFS and OS for resected low-grade ENB were 5.4 and 20.5 years, respectively. Conversely, median DFS and OS for high-grade ENB were 1.5 and 2.5 years, respectively. CONCLUSION: Low and high-grade ENB display distinct patterns at presentation and relapse, leading to different prognosis. Therefore, they may be regarded as distinct entities.
Authors: Hedyeh Ziai; Eugene Yu; Terence Fu; Nidal Muhanna; Eric Monteiro; Allan Vescan; Gelareh Zadeh; Ian J Witterick; David P Goldstein; Fred Gentili; John R de Almeida Journal: J Neurol Surg B Skull Base Date: 2017-12-29
Authors: John P Marinelli; Jeffrey R Janus; Jamie J Van Gompel; Michael J Link; Eric J Moore; Kathryn M Van Abel; Brandon W Peck; Christine M Lohse; Daniel L Price Journal: J Neurol Surg B Skull Base Date: 2018-02-22
Authors: Diana Bell; Rami Saade; Dianna Roberts; Thomas J Ow; Michael Kupferman; Franco DeMonte; Ehab Y Hanna Journal: Head Neck Pathol Date: 2014-05-08
Authors: Bobby A Tajudeen; Armin Arshi; Jeffrey D Suh; Miguel Fernando Palma-Diaz; Marvin Bergsneider; Elliot Abemayor; Maie St John; Marilene B Wang Journal: J Neurol Surg B Skull Base Date: 2014-09-13
Authors: Rohan R Joshi; Qasim Husain; Benjamin R Roman; Jennifer Cracchiolo; Yao Yu; Jillian Tsai; Julie Kang; Sean McBride; Nancy Y Lee; Luc Morris; Ian Ganly; Viviane Tabar; Marc A Cohen Journal: J Surg Oncol Date: 2018-11-22 Impact factor: 3.454
Authors: Neeraja Konuthula; Alfred M Iloreta; Brett Miles; Ryan Rhome; Umut Ozbek; Eric M Genden; Marshall Posner; Krzysztof Misiukiewicz; Satish Govindaraj; Raj Shrivastava; Vishal Gupta; Richard L Bakst Journal: Head Neck Date: 2017-08-17 Impact factor: 3.147
Authors: Khodayar Goshtasbi; Arash Abiri; Mehdi Abouzari; Ronald Sahyouni; Beverly Y Wang; Bobby A Tajudeen; Frank P K Hsu; Gilbert Cadena; Edward C Kuan Journal: Int Forum Allergy Rhinol Date: 2019-06-28 Impact factor: 3.858